An attempt to regress cardiac hypertrophy by cardiomyocyte intracellular calmodulin control

通过心肌细胞内钙调蛋白控制来逆转心脏肥大的尝试

基本信息

  • 批准号:
    16K15443
  • 负责人:
  • 金额:
    $ 2.25万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 财政年份:
    2016
  • 资助国家:
    日本
  • 起止时间:
    2016-04-01 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Channel Pore Mutation of RyR2 Cause Calcium Leak Independent of FKBP12.6-RyR2 and Calmodulin-RyR2 Affinity in R4496C/+ Knock-in Mouse
R4496C/敲入小鼠中 RyR2 的通道孔突变导致钙渗漏,与 FKBP12.6-RyR2 和钙调蛋白-RyR2 亲和力无关
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hitoshi Uchinoumi;Ivanita Stefanon;Yi Yang;Mena Said;Xiaoqiong Dong;Rogerio Faustino;Jose L Puglisi;Ye Chen-Izu;Razvan L Cornea;Xander H Wehrens;Wayne S Chen;Takeshi Yamamoto;Yano Masafumi and Donald M Bers
  • 通讯作者:
    Yano Masafumi and Donald M Bers
Nuclear Translocation of Calmodulin, Which Dissociated From Cardiac Ryanodine Receptor, Promotes the Pathological Cardiac Hypertrophy
从心脏兰尼丁受体解离的钙调蛋白的核转位促进病理性心脏肥大
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tetsuro Oda;Takeshi Yamamoto;Takayoshi Kato;Shigehiko Nishimura;Go Fukui;Shinichi Okuda;Shigeki Kobayashi;Donald Bers and Masafumi Yano
  • 通讯作者:
    Donald Bers and Masafumi Yano
Stabilization of Camkii-Phosphorylated Ryr2 by Dantrolene Prevents the Development of Age-Related Cardiomyopathy Caused by CamkiiδC Overexpression
Dantrolene 对 Camkii 磷酸化 Ryr2 的稳定可预防由 CamkiiδC 过度表达引起的年龄相关性心肌病的发展
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoko S Shimizu;Shinichi Okuda;Yoko Okamoto;Shigehiko Nishimura;Takayoshi Kato;Tetsuro Oda;Shigeki Kobayashi;Takeshi Yamamoto and Masafumi Yano
  • 通讯作者:
    Takeshi Yamamoto and Masafumi Yano
Mutation-linked, excessively tight interaction between the calmodulin binding domain and the C-terminal domain of the cardiac ryanodine receptor as a novel cause of catecholaminergic polymorphic ventricular tachycardia.
钙调蛋白结合域和心脏兰尼碱受体 C 端域之间突变相关的过度紧密相互作用是儿茶酚胺能多形性室性心动过速的新原因。
  • DOI:
    10.1016/j.hrthm.2018.02.006
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Nishimura S;Yamamoto T;Nakamura Y;Kohno M;Hamada Y;Sufu Y;Fukui G;Nanno T;Ishiguchi H;Kato T;Xu X;Ono M;Oda T;Okuda S;Kobayashi S;Yano M.
  • 通讯作者:
    Yano M.
Correction of the Defective Channel Gating of Cardiac Ryanodine Receptor Improves Cardiac Function and Suppresses Ventricular Arrhythmia in Post Myocardial Infarction Heart Failure
纠正心脏兰尼丁受体通道门控缺陷可改善心肌梗死后心力衰竭的心功能并抑制室性心律失常
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hironori Ishiguchi;Shigeki Kobayashi;Michiaki Kohno;Takuma Nanno;Gou Fukui;Yoko Sufu-Shimizu;Yoriomi Hamada;Takako Maeda;Shigehiko Nishimura;Tetsuro Oda;Shinnichi Okuda;Takeshi Ueyama;Takeshi Yamamoto;Masafumi Yano
  • 通讯作者:
    Masafumi Yano
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YANO Masafumi其他文献

Real-time Control of Bipedal Movement based on Basal ganglia and Brainstem Systems
基于基底神经节和脑干系统的双足运动实时控制

YANO Masafumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YANO Masafumi', 18)}}的其他基金

Comprehensive treatment of heart failure, cardiac hypertrophy, and arrhythmia by controlling ryanodine receptor bound calmodulin
通过控制兰尼碱受体结合钙调蛋白综合治疗心力衰竭、心脏肥大和心律失常
  • 批准号:
    17H04178
  • 财政年份:
    2017
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New molecular targeting therapy for regression of cardiac hypertrophy by inhibiting abnormal Ca2+ leak through RyR2 in hypertrophic cardiomyopathy
通过 RyR2 抑制异常 Ca2 渗漏来消退肥厚型心肌病的新型分子靶向治疗
  • 批准号:
    26670404
  • 财政年份:
    2014
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Comprehensive strategy of heart failure, cardiac hypertrophy and lethal arrhythmia via stabilizing the stricture of ryanodine receptor
通过稳定兰尼碱受体狭窄治疗心力衰竭、心肌肥厚和致死性心律失常的综合策略
  • 批准号:
    26293189
  • 财政年份:
    2014
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of comprehensive treatment of heart failure, hypertrophy, and arrhythmia by regulating intracellular Ca
调节细胞内Ca综合治疗心力衰竭、肥厚、心律失常的进展
  • 批准号:
    23390215
  • 财政年份:
    2011
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of therapeutic therapy for regression of cardiac hypertrophy in hypertrophic cardiomyopathy
肥厚型心肌病心肌肥厚消退治疗方法的开发
  • 批准号:
    22659154
  • 财政年份:
    2010
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of new therapy for heart failure and arrhythmia by correction of signal transduction within cardiac ryanodine receptor
通过校正心脏兰尼碱受体内的信号转导开发心力衰竭和心律失常的新疗法
  • 批准号:
    20390226
  • 财政年份:
    2008
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of molecular targeting therapy for duonic heart failure bystabilizmgryanodine receptor
稳定麦草碱受体治疗双元心力衰竭分子靶向治疗的建立
  • 批准号:
    18390234
  • 财政年份:
    2006
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Computational study on acoustic-image perception of object-shape from single-emission echo in bats
蝙蝠单次发射回声物体形状声像感知的计算研究
  • 批准号:
    17500190
  • 财政年份:
    2005
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Research in the inhibitory effect of sarcoplasmic reticulum Ca release channel stabilizer on the development of heart failure
肌浆网钙释放通道稳定剂抑制心力衰竭发展的研究
  • 批准号:
    13670717
  • 财政年份:
    2001
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Assessment of cardiac excitation-contraction coupling and effect of positive inctropic agent on Ca^<2+> regulating function of sarcoplasmic reticulum in heart failan
心衰患者心脏兴奋-收缩耦合及正性收缩剂对肌浆网Ca^2调节功能的影响
  • 批准号:
    11670684
  • 财政年份:
    1999
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

カルモジュリンの核内移行制御による新しい心不全・心肥大の治療
通过控制钙调蛋白核转位治疗心力衰竭和心脏肥大的新方法
  • 批准号:
    21K08054
  • 财政年份:
    2021
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel molecular targeted therapy by stabilizing cardiac ryanodine receptors in hypertrophic cardiomyopathy
通过稳定心脏兰尼碱受体开发新型分子靶向治疗肥厚型心肌病
  • 批准号:
    18K08076
  • 财政年份:
    2018
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel treatment of arrhythmia and heart failure by controlling the domain of ryanodine receptors
通过控制兰尼碱受体结构域治疗心律失常和心力衰竭
  • 批准号:
    18K08108
  • 财政年份:
    2018
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms of myocardial ischemia/reperfusion injury mediated through transient receptor potential canonical (TRPC) channels, and establishment of new therapeutics for its treatment.
阐明通过瞬时受体电位经典(TRPC)通道介导的心肌缺血/再灌注损伤的机制,并建立新的治疗方法。
  • 批准号:
    17K08536
  • 财政年份:
    2017
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Comprehensive treatment of heart failure, cardiac hypertrophy, and arrhythmia by controlling ryanodine receptor bound calmodulin
通过控制兰尼碱受体结合钙调蛋白综合治疗心力衰竭、心脏肥大和心律失常
  • 批准号:
    17H04178
  • 财政年份:
    2017
  • 资助金额:
    $ 2.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了